Arkolith/Insider Trading/CRBU/Form 4

Kelly Timothy P

Chief Technology OfficerCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Feb 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Sell(S)3K$1.96$6K79K
Feb 20, 2026Grant(A)45K—$083K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2026Grant(A)203K—$0203K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001754067-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML